Verwandte Artikel zu AI-Driven Innovations in Genome, Epigenome, and Mitochondria...
Inhaltsangabe
Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorin bzw. den Autor
Anmol Budhewar serves as an Assistant Professor in Computer Engineering, with research interests spanning artificial intelligence, machine learning, blockchain-enabled systems, and secure computing architectures. In the previous academic year, he published one Scopus-indexed research article and one IEEE international conference paper, demonstrating his commitment to high-quality scholarly dissemination. He contributes extensively to the academic peer-review ecosystem, serving as a reviewer for multiple international journals and edited books, and earning several Certificates of Excellence for review quality. Notably, he reviewed four research articles for SN Computer Science (Springer Nature) on topics including blockchain security, medical image analysis, fraud detection, and authentication systems. His academic work emphasizes integrating intelligent computational models with real-world applications in healthcare, cybersecurity, and data-driven decision systems. Through research, reviewing, and teaching, he strengthens methodological rigor and interdisciplinary innovation in computer engineering.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Suchergebnisse für AI-Driven Innovations in Genome, Epigenome, and Mitochondria...
Beispielbild für diese ISBN
AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies
Anbieter: California Books, Miami, FL, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Artikel-Nr. I-9798260001615
Neu kaufen
EUR 299,99
EUR 2,72 Versand
Versand innerhalb von USA
Versand innerhalb von USA
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies
Anbieter: Home-set, Mannheim, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Gebundene Ausgabe. Zustand: Neu. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. Sprache: Englisch Gewicht in Gramm: 1119. Artikel-Nr. IB-17237348
Neu kaufen
EUR 372,25
EUR 60,98 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 2 verfügbar